Company: WELNF
Filing Date: 2025-12-18
Form Type: 425
Source: 0001104659-25-122571
Chunk: 2

Company: Integrated Wellness Acquisition Corp
Filing Date: 2025-12-18
Form: 425
Chunk 2
---
ertain inputs that may change prior to the closing of the Business Combination and is subject to adjustment after the closing of the
Business Combination), the level of redemptions of the Company’s public shareholders and the products and markets and expected future
performance and market opportunities of Btab. These forward-looking statements generally are identified by the words “believe,”
“project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,”
“future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,”
“will be,” “will continue,” “will likely result” and similar expressions, but the absence of these
words does not mean that a statement is not forward-looking. Forward-looking statements are predictions, projections and other statements
about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many
factors could cause actual future events to differ materially from the forward-looking statements in this Current Report on Form 8-K,
including but not limited to: (i) the risk that the proposed Business Combination may not be completed in a timely manner or at all, which
may adversely affect the price of the Company’s securities; (ii) the risk that the proposed Business Combination may not be completed
by the Company’s Business Combination deadline; (iii) the failure to satisfy the conditions to the consummation of the Business
Combination; (iv) the occurrence of any event, change or other circumstance that could give rise to the termination of the Business Combination
Agreement; (v) the failure to achieve the minimum amount of cash available following any redemptions by the Company’s shareholders;
(vi) redemptions exceeding a maximum threshold or the failure to meet the Nasdaq’s initial listing standards in connection with
the consummation of the contemplated Business Combination; (vii) the effect of the announcement or pendency of the Business Combination
on Btab’s business relationships, operating results, and business generally; (viii) risks that the proposed Business Combination
disrupts current plans and operations of Btab; (ix) the outcome of any legal proceedings that may be instituted against Btab or against
the Company related to the Business Combination Agreement or the proposed Business Combination; and (x) those factors discussed in the
Company’s filings with the Securities and Exchange Commission (“SEC”) and in the Proxy Statements (as defined
below). Shareholders should carefully consider the risks